Insider Transactions in Q3 2021 at Morphic Holding, Inc. (MORF)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 16
2021
|
Peter Linde Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,000
-9.16%
|
$260,000
$65.92 P/Share
|
Sep 16
2021
|
Peter Linde Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,378
+40.46%
|
-
|
Sep 13
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
3,049
-23.37%
|
$198,185
$65.01 P/Share
|
Sep 13
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,721
-1.88%
|
$111,865
$65.0 P/Share
|
Sep 13
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,721
+1.84%
|
$6,884
$4.32 P/Share
|
Sep 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
SELL
Open market or private sale
|
Direct |
9,859
-43.04%
|
$640,835
$65.14 P/Share
|
Sep 10
2021
|
Robert E Farrell Jr SVP Finance and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,974
+17.84%
|
$19,896
$4.32 P/Share
|
Sep 10
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
8,279
-8.43%
|
$538,135
$65.11 P/Share
|
Sep 10
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,279
+7.78%
|
$33,116
$4.32 P/Share
|
Sep 09
2021
|
Bruce Rogers PRESIDENT |
SELL
Open market or private sale
|
Direct |
30,000
-8.85%
|
$1,800,000
$60.82 P/Share
|
Sep 09
2021
|
Bruce Rogers PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+20.01%
|
$120,000
$4.32 P/Share
|
Aug 20
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
11,620
+0.63%
|
$650,720
$56.4 P/Share
|
Aug 19
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
33,000
+1.21%
|
$1,815,000
$55.95 P/Share
|
Aug 18
2021
|
Timothy A Springer |
BUY
Open market or private purchase
|
Indirect |
30,307
+1.72%
|
$1,666,885
$55.88 P/Share
|